Sensorcaine Mpf

BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE · BUPIVACAINE HYDROCHLORIDE 5 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL · Injection, Solution · Epidural; Intracaudal; Perineural · Fresenius Kabi USA, LLC

NDC 63323-0462-31 · 5 VIAL, SINGLE-DOSE in 1 BOX / 30 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “delay in shipping of the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed

$41.30

Reported to Texas DSHS · 2026 annual filing · Fresenius Kabi USA

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$884

230 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Fresenius Kabi USA, LLCUnited States
analysis · manufacture

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: NDA018304
TE code: AP
Approval date: Jan 1, 1982
Patents / exclusivity: None on file

Shortage history

In shortage now — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31)Feb 20, 2018
Delay in shipping of the drug
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months
In shortage now — Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 21% odds it resolves within 6 months

Recalls (this NDC)

Class II · TerminatedDec 10, 2020
Fresenius Kabi USA, LLC — Subpotent Drug: Low out-of-specification assay results for the epinephrine component.

Manufacturers of BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE (Injection, Solution)

Labeler	Strength	First seen	Last seen
Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL	Jul 15, 2026	Sep 3, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL; EPINEPHRINE BITARTRATE .0091 mg/mL	Jul 15, 2026	Sep 3, 2026
Septodont, Inc.	BUPIVACAINE HYDROCHLORIDE ANHYDROUS 5 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL	Jul 15, 2026	Sep 3, 2026
Sportpharm LLC	BUPIVACAINE HYDROCHLORIDE 5 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL	Sep 3, 2026	Sep 3, 2026
Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL	Jul 15, 2026	Sep 2, 2026
Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL; EPINEPHRINE BITARTRATE .0091 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE 5 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mL	Jul 15, 2026	Aug 31, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 5 mg/mL; EPINEPHRINE BITARTRATE .0091 mg/mL	Jul 15, 2026	Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sensorcaine Mpf — NDC 63323-0462-31," retrieved September 3, 2026, https://drugdashboards.com/drug/63323046231.

Free to cite with attribution — see how the data is put together.